1
|
Okuno R, Inoue Y, Hasebe Y, Igarashi T, Kawagishi-Hotta M, Yamada T, Hasegawa S. Genome-wide association studies in the Japanese population identified genetic loci and target gene associated with epidermal turnover. Exp Dermatol 2023; 32:1856-1863. [PMID: 37551986 DOI: 10.1111/exd.14908] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2022] [Revised: 05/10/2023] [Accepted: 07/31/2023] [Indexed: 08/09/2023]
Abstract
The epidermis is an essential organ for life by retaining water and as a protective barrier. The epidermis is maintained through metabolism, in which basal cells produced from epidermal stem cells differentiate into spinous cells, granular cells and corneocytes, and are finally shed from the epidermal surface. This is epidermal turnover, and with aging, there is a decline in epidermis function. Other factors that may affect epidermal turnover include ultraviolet damage and genetic factors. These genetic factors are of particular interest as little is known. Although recent skin-focused genome-wide association studies (GWAS) have been conducted, the genetic regions associated with epidermal turnover are almost uninvestigated. Therefore, we conducted a GWAS on epidermal turnover in the Japanese population, using the corneocyte area, which correlates to the rate of epidermal turnover, as an indicator. As a result, rs2278431 (p = 1.29 × 10-7 ) in 19q13.2 was associated with corneocyte size. Furthermore, eQTL analysis suggested that rs2278431 was related to the SPINT2 gene. In addition, SPINT2 knockdown studies using epidermal keratinocytes revealed that SPINT2 is involved in keratinocyte proliferation and in corneocyte size regulation in reconstructed epidermis. These results suggest that rs2278431 is involved in the expression of SPINT2 and affects epidermal turnover.
Collapse
Affiliation(s)
- Ryosuke Okuno
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd., Nagoya, Japan
- Nagoya University-MENARD Collaborative Research Chair, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Yu Inoue
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd., Nagoya, Japan
- Nagoya University-MENARD Collaborative Research Chair, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Yuichi Hasebe
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd., Nagoya, Japan
- Nagoya University-MENARD Collaborative Research Chair, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Toshio Igarashi
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd., Nagoya, Japan
| | - Mika Kawagishi-Hotta
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd., Nagoya, Japan
- Nagoya University-MENARD Collaborative Research Chair, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Takaaki Yamada
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd., Nagoya, Japan
| | - Seiji Hasegawa
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd., Nagoya, Japan
- Nagoya University-MENARD Collaborative Research Chair, Nagoya University Graduate School of Medicine, Nagoya, Japan
| |
Collapse
|
2
|
Kawagishi-Hotta M, Hasegawa S, Hasebe Y, Inoue Y, Okuno R, Arima M, Iwata Y, Sugiura K, Akamatsu H. Increase in Inhibin beta A/Activin-A expression in the human epidermis and the suppression of epidermal stem/progenitor cell proliferation with aging. J Dermatol Sci 2022; 106:150-158. [DOI: 10.1016/j.jdermsci.2022.05.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2021] [Revised: 03/21/2022] [Accepted: 05/05/2022] [Indexed: 11/25/2022]
|
3
|
Kawagishi-Hotta M, Hasegawa S, Inoue Y, Hasebe Y, Arima M, Iwata Y, Sugiura K, Akamatsu H. Gremlin 2 suppresses differentiation of stem/progenitor cells in the human skin. Regen Ther 2021; 18:191-201. [PMID: 34307797 PMCID: PMC8280529 DOI: 10.1016/j.reth.2021.06.007] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2021] [Revised: 05/30/2021] [Accepted: 06/24/2021] [Indexed: 11/19/2022] Open
Abstract
INTRODUCTION The skin is comprised of various kinds of cells and has three layers, the epidermis, dermis and subcutaneous adipose tissue. Stem cells in each tissue duplicate themselves and differentiate to supply new cells that function in the tissue, and thereby maintain the tissue homeostasis. In contrast, senescent cells accumulate with age and secrete senescence-associated secretory phenotype (SASP) factors that impair surrounding cells and tissues, which lowers the capacity to maintain homeostasis in each tissue. Previously, we found Gremlin 2 (GREM2) as a novel SASP factor in the skin and reported that GREM2 suppressed the differentiation of adipose-derived stromal/stem cells. In the present study, we investigated the effects of GREM2 on stem cells in the epidermis and dermis. METHODS To examine whether GREM2 expression and the differentiation levels in the epidermis and dermis are correlated, the expressions of GREM2, stem cell markers, an epidermal differentiation marker Keratin 10 (KRT10) and a dermal differentiation marker type 3 procollagen were examined in the skin samples (n = 14) randomly chosen from the elderly where GREM2 expression level is high and the individual differences of its expression are prominent. Next, to test whether GREM2 affects the differentiation of skin stem cells, cells from two established lines (an epidermal and a dermal stem/progenitor cell model) were cultured and induced to differentiate, and recombinant GREM2 protein was added. RESULTS In the human skin, the expression levels of GREM2 varied among individuals both in the epidermis and dermis. The expression level of GREM2 was not correlated with the number of stem cells, but negatively correlated with those of both an epidermal and a dermal differentiation markers. The expression levels of epidermal differentiation markers were significantly suppressed by the addition of GREM2 in the three-dimensional (3D) epidermis generated with an epidermal stem/progenitor cell model. In addition, by differentiation induction, the expressions of dermal differentiation markers were induced in cells from a dermal stem/progenitor cell model, and the addition of GREM2 significantly suppressed the expressions of the dermal differentiation markers. CONCLUSIONS GREM2 expression level did not affect the numbers of stem cells in the epidermis and dermis but affects the differentiation and maturation levels of the tissues, and GREM2 suppressed the differentiation of stem/progenitor cells in vitro. These findings suggest that GREM2 may contribute to the age-related reduction in the capacity to maintain skin homeostasis by suppressing the differentiation of epidermal and dermal stem/progenitor cells.
Collapse
Affiliation(s)
- Mika Kawagishi-Hotta
- Research Laboratories, Nippon Menard Cosmetic Co., LTD., Japan
- Nagoya University-MENARD Collaborative Research Chair, Nagoya University Graduate School of Medicine, Japan
- Department of Applied Cell and Regenerative Medicine, Fujita Health University School of Medicine, Japan
| | - Seiji Hasegawa
- Research Laboratories, Nippon Menard Cosmetic Co., LTD., Japan
- Nagoya University-MENARD Collaborative Research Chair, Nagoya University Graduate School of Medicine, Japan
- Department of Dermatology, Fujita Health University School of Medicine, Japan
| | - Yu Inoue
- Research Laboratories, Nippon Menard Cosmetic Co., LTD., Japan
- Nagoya University-MENARD Collaborative Research Chair, Nagoya University Graduate School of Medicine, Japan
| | - Yuichi Hasebe
- Research Laboratories, Nippon Menard Cosmetic Co., LTD., Japan
- Nagoya University-MENARD Collaborative Research Chair, Nagoya University Graduate School of Medicine, Japan
| | - Masaru Arima
- Department of Dermatology, Fujita Health University School of Medicine, Japan
| | - Yohei Iwata
- Department of Dermatology, Fujita Health University School of Medicine, Japan
| | - Kazumitsu Sugiura
- Department of Dermatology, Fujita Health University School of Medicine, Japan
| | - Hirohiko Akamatsu
- Department of Applied Cell and Regenerative Medicine, Fujita Health University School of Medicine, Japan
| |
Collapse
|
4
|
Inoue Y, Hasegawa S, Hasebe Y, Kawagishi-Hotta M, Okuno R, Yamada T, Adachi H, Miyachi K, Ishii Y, Sugiura K, Akamatsu H. Establishment of Three Types of Immortalized Human Skin Stem Cell Lines Derived from the Single Donor. Biol Pharm Bull 2021; 44:1403-1412. [PMID: 34602549 DOI: 10.1248/bpb.b21-00058] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Currently, human-skin derived cell culture is a basic technique essential for dermatological research, cellular engineering research, drug development, and cosmetic development. But the number of donors is limited, and primary cell function reduces through cell passage. In particular, since adult stem cells are present in a small amount in living tissues, it has been difficult to obtain a large amount of stem cells and to stably culture them. In this study, skin derived cells were isolated from the epidermis, dermis, and adipose tissue collected from single donor, and immortalization was induced through gene transfer. Subsequently, cell lines that could be used as stem cell models were selected using the differentiation potential and the expression of stem cell markers as indices, and it was confirmed that these could be stably cultured. The immortalized cell lines established in this study have the potential to be applied not only to basic dermatological research but also to a wide range of fields such as drug screening and cell engineering.
Collapse
Affiliation(s)
- Yu Inoue
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd.,Nagoya University-MENARD Collaborative Research Chair, Nagoya University Graduate School of Medicine
| | - Seiji Hasegawa
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd.,Nagoya University-MENARD Collaborative Research Chair, Nagoya University Graduate School of Medicine.,Department of Dermatology, Fujita Health University School of Medicine
| | - Yuichi Hasebe
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd.,Nagoya University-MENARD Collaborative Research Chair, Nagoya University Graduate School of Medicine
| | - Mika Kawagishi-Hotta
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd.,Nagoya University-MENARD Collaborative Research Chair, Nagoya University Graduate School of Medicine.,Department of Applied Cell and Regenerative Medicine, Fujita Health University School of Medicine
| | - Ryosuke Okuno
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd.,Nagoya University-MENARD Collaborative Research Chair, Nagoya University Graduate School of Medicine
| | - Takaaki Yamada
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd.,Department of Dermatology, Fujita Health University School of Medicine.,Department of Applied Cell and Regenerative Medicine, Fujita Health University School of Medicine
| | | | | | - Yoshie Ishii
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd.,Department of Applied Cell and Regenerative Medicine, Fujita Health University School of Medicine
| | - Kazumitsu Sugiura
- Department of Dermatology, Fujita Health University School of Medicine
| | - Hirohiko Akamatsu
- Department of Applied Cell and Regenerative Medicine, Fujita Health University School of Medicine
| |
Collapse
|
5
|
Yoshioka H, Yamada T, Hasegawa S, Miyachi K, Ishii Y, Hasebe Y, Inoue Y, Tanaka H, Iwata Y, Arima M, Sugiura K, Akamatsu H. Senescent cell removal via JAG1-NOTCH1 signalling in the epidermis. Exp Dermatol 2021; 30:1268-1278. [PMID: 33891780 DOI: 10.1111/exd.14361] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2020] [Revised: 03/09/2021] [Accepted: 04/15/2021] [Indexed: 12/13/2022]
Abstract
Emerging evidence has pointed to the noxious effects of senescent cells in various tissues, and senescent cells in the epidermis are known to accumulate with age. We hypothesized that there is a mechanism by which senescent cells in the epidermis are preferentially removed and that the function of such removal mechanism declines as age increases. In this study, we investigated whether Notch signalling is involved in such senescent cell removal. We found that Notch1 receptor was expressed more highly in p16INK4a-positive senescent cells than in surrounding cells in human epidermis both in young and old subjects. On the other hand, the expression of its ligand JAG1 was decreased in the epidermis of aged subjects. When normal epidermal cells and UVB-irradiated senescent cells were mixed and three-dimensional reconstructed epidermis was developed in vitro, the senescent cells were preferentially removed from the basal layer and located in the upper layer. We also found that the depletion of senescent cells from the basal layer was suppressed by JAG1 knockdown in normal cells or using a Notch signalling inhibitor. From these results, Notch signalling may be involved in senescent cell removal in the epidermis and the age-related decrease of JAG1 expression in the basal layer may lead to accumulation of senescent cells owing to reduced activation of Notch signalling.
Collapse
Affiliation(s)
- Hisashi Yoshioka
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd., Nagoya, Japan
| | - Takaaki Yamada
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd., Nagoya, Japan.,Department of Applied Cell and Regenerative Medicine, Fujita Health University School of Medicine, Toyoake, Japan.,Department of Dermatology, Fujita Health University School of Medicine, Toyoake, Japan
| | - Seiji Hasegawa
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd., Nagoya, Japan.,Department of Dermatology, Fujita Health University School of Medicine, Toyoake, Japan.,Nagoya University-MENARD Collaborative Chair, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Katsuma Miyachi
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd., Nagoya, Japan
| | - Yoshie Ishii
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd., Nagoya, Japan.,Department of Applied Cell and Regenerative Medicine, Fujita Health University School of Medicine, Toyoake, Japan
| | - Yuichi Hasebe
- Nagoya University-MENARD Collaborative Chair, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Yu Inoue
- Nagoya University-MENARD Collaborative Chair, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Hiroshi Tanaka
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd., Nagoya, Japan
| | - Yohei Iwata
- Department of Dermatology, Fujita Health University School of Medicine, Toyoake, Japan
| | - Masaru Arima
- Department of Dermatology, Fujita Health University School of Medicine, Toyoake, Japan
| | - Kazumitsu Sugiura
- Department of Dermatology, Fujita Health University School of Medicine, Toyoake, Japan
| | - Hirohiko Akamatsu
- Department of Applied Cell and Regenerative Medicine, Fujita Health University School of Medicine, Toyoake, Japan
| |
Collapse
|